(Q36690285)

15 August 2017

1 reference

title

Optimization and delivery of plasmid DNA for vaccination (English)

1 reference

15 August 2017

Wolfgang Jechlinger

1

1 reference

15 August 2017

1 December 2006

1 reference

Expert Review of Vaccines

15 August 2017

1 reference

15 August 2017

5

1 reference

15 August 2017

6

1 reference

15 August 2017

803-825

1 reference

Human vaccine research and development: an overview

15 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Antigen presentation and DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Rapid-response vaccines--does DNA offer a solution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

DNA vaccines--back in the saddle again?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Genetic immunization: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Induction of immune responses by DNA vaccines in large animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Approaches to enhance the efficacy of DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

A new DNA vehicle for nonviral gene delivery: supercoiled minicircle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Genetic adjuvants for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

DNA-based therapeutics and DNA delivery systems: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Gene delivery with synthetic (non viral) carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Development of improved vectors for DNA-based immunization and other gene therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Diverse plasmid DNA vectors by directed molecular evolution of cytomegalovirus promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

A composite CMV-IE enhancer/beta-actin promoter is ubiquitously expressed in mouse cutaneous epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Comparative study of immune responses induced after immunization with plasmids encoding the HIV-1 Nef protein under the control of the CMV-IE or the muscle-specific desmin promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Generation of a synthetic mammalian promoter library by modification of sequences spacing transcription factor binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

The hybrid cytomegalovirus enhancer/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Modulating gene expression using DNA vaccines with different 3'-UTRs influences antibody titer, seroconversion and cytokine profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Immunotherapeutic uses of CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

An improved plasmid DNA expression vector for direct injection into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Animal-free production of ccc-supercoiled plasmids for research and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Cancer Gene Therapy Using Plasmid DNA: Purification of DNA for Human Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Preparative purification of supercoiled plasmid DNA using anion-exchange chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Affinity adsorption of plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Immobilization of plasmid DNA in bacterial ghosts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Efficient purification of plasmid DNA for gene transfer using triple-helix affinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Purification of plasmids by triplex affinity interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

DNA immunisation with minimalistic expression constructs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Effect of different nuclear localization sequences on the immune responses induced by a MIDGE vector encoding bovine herpesvirus-1 glycoprotein D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Immunization with DNA through the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Particle-mediated nucleic acid immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Genetic immunization by jet injection of targeted pDNA-coated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Gene therapy progress and prospects: electroporation and other physical methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

In vivo electroporation and ubiquitin promoter--a protocol for sustained gene expression in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Femtosecond infrared laser-an efficient and safe in vivo gene delivery system for prolonged expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Nanoscopic structure of DNA condensed for gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Non-viral gene therapy: polycation-mediated DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Design and gene delivery activity of modified polyethylenimines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

In vitro gene delivery to hepatocytes with galactosylated polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Current status of polymeric gene delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Dendrimers in gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Physicochemical optimisation of plasmid delivery by cationic lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

A role for liposomes in genetic vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Lipid-based systems for the intracellular delivery of genetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Folate-targeted gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Virus-like particles: designing an effective AIDS vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

In vitro gene transfer using human papillomavirus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Bacteria as DNA vaccine carriers for genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Bacterial invasion: the paradigms of enteroinvasive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Attenuated salmonella and Shigella as carriers for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Diversity of prokaryotic chromosomal proteins and the origin of the nucleosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Efficacy of a DNA vaccine delivered in attenuated Salmonella typhimurium against Eimeria tenella infection in chickens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Bacterial gene therapy strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella enterica Serovar typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Plasmid maintenance systems suitable for GMO-based bacterial vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Bacterial ghosts: non-living candidate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Bacterial ghosts as antigen delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Bacterial ghosts are an efficient delivery system for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

21 January 2018

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

Anionic polyethyleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation time

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.803

21 January 2018

Identifiers

DOI

10.1586/14760584.5.6.803

1 reference

15 August 2017

1 reference

PubMed ID

17184219